I suspect, btw, that the Google model in this paper https://www.nature.com/articles/s41586-019-1799-6
will show stronger performance. But Kheiron appears to be ahead as far as proving the value of the tool since they have actually validated prospectively.
You certainly said that screening leads to over diagnosis.
I think for screening, the best results are probably the upcoming prospective study from Kheiron.
https://www.kheironmed.com/news/press-release-new-results-sh...